Risk stratification in acute pulmonary embolism: Frequency and impact on treatment decisions and outcomes

Southern Medical Journal

Volumn 107, Issue 2, 2014, Pages 72-78

  Stamm, Jason A ^a   Long, Joshua L ^a   Kirchner, Lester ^a   Keshava, Keerthana ^a   Wood, Kenneth E ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

Echocardiography; Mortality; Natriuretic peptide; Pulmonary embolism; Troponin; Venous thromboembolism

Indexed keywords

FIBRINOLYTIC AGENT; GLUCOSE; LACTIC ACID; NATRIURETIC FACTOR; TROPONIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD CLOT LYSIS; CLINICAL ASSESSMENT TOOL; CLINICAL DECISION MAKING; COHORT ANALYSIS; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; GLUCOSE BLOOD LEVEL; HEALTH CARE QUALITY; HEALTH IMPACT ASSESSMENT; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; LACTATE BLOOD LEVEL; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PULMONARY EMBOLISM SEVERITY INDEX; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SEX RATIO; TEACHING HOSPITAL; UREA NITROGEN BLOOD LEVEL; VENA CAVA FILTER;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; DECISION MAKING; ELECTROCARDIOGRAPHY; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TROPONIN; UNITED STATES;

EID: 84898411784     PISSN: 00384348     EISSN: 15418243     Source Type: Journal    
DOI: 10.1097/SMJ.0000000000000053     Document Type: Article

References (34)

1. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998;158: 585-593.
2. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991;151: 933-938.
3. Kasper W, Konstantinides S, Geibel A, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997;30: 1165-1171.
4. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353: 1386-1389.
5. Spencer FA, Goldberg RJ, Lessard D, et al. Factors associated with adverse outcomes in outpatients presenting with pulmonary embolism: the Worcester Venous Thromboembolism Study. Circ Cardiovasc Qual Outcomes 2010;3: 390-394.
6. Grifoni S, Olivotto I, Cecchini P, et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation 2000;101: 2817-2822.
7. Vieillard-Baron A, Page B, Augarde R, et al. Acute cor pulmonale in massive pulmonary embolism: incidence, echocardiographic pattern, clinical implications and recovery rate. Intensive Care Med 2001;27: 1481-1486.
8. Kucher N, Rossi E, De Rosa M, et al. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med 2005;165: 1777-1781.
9. Sanchez O, Trinquart L, Colombet I, et al. Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. Eur Heart J 2008;29: 1569-1577.
10. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition). Chest 2008;133: 454SY545S.
11. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008;29: 2276-2315.
12. Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011;123: 1788-1830.
13. Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005;172: 1041-1046.
14. Binder L, Pieske B, Olschewski M, et al. N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 2005;112: 1573-1579.
15. Fremont B, Pacouret G, Jacobi D, et al. Prognostic value of echocardiographic right/left ventricular end-diastolic diameter ratio in patients with acute pulmonary embolism: results from a monocenter registry of 1,416 patients. Chest 2008;133: 358-362.
16. Lega JC, Lacasse Y, Lakhal L, et al. Natriuretic peptides and troponins in pulmonary embolism: a meta-analysis. Thorax 2009;64: 869-875.
17. Sanchez O, Trinquart L, Caille V, et al. Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study. Am J Respir Crit Care Med 2010;181: 168-173.
18. Konstantinides S, Geibel A, Heusel G, et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002;347: 1143-1150.
19. Aujesky D, Roy PM, Verschuren F, et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 2011;378: 41-48.
20. Steering Committee. Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial. Am Heart J 2012;163: 33.e1-38.e1.
21. Stein PD, Matta F, Keyes DC, et al. Impact of vena cava filters on inhospital case fatality rate from pulmonary embolism. Am J Med 2012;125: 478-484.
22. Donze J, Le Gal G, Fine MJ, et al. Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism. Thromb Haemost 2008;100: 943-948.
23. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141: e419SYe494S.
24. Klok FA, ZondagW, van KralingenKW, et al. Patient outcomes after acute pulmonary embolism. A pooled survival analysis of different adverse events. Am J Respir Crit Care Med 2010;181: 501-506.
25. Stein PD, Matta F. Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused. Am J Med 2012;125: 465-470.
26. Stein PD, Matta F, Hull RD. Increasing use of vena cava filters for prevention of pulmonary embolism. Am J Med 2011;124: 655-661.
27. Kucher N, Rossi E, De Rosa M, et al. Massive pulmonary embolism. Circulation 2006;113: 577-582.
28. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med 1992;326: 1240-1245.
29. Todd JL, Tapson VF. Thrombolytic therapy for acute pulmonary embolism: a critical appraisal. Chest 2009;135: 1321-1329.
30. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 1998;338: 409-415.
31. Fiumara K, Kucher N, Fanikos J, et al. Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism. Am J Cardiol 2006;97: 127-129.
32. Stein PD, Kayali F, Olson RE. Twenty-one-year trends in the use of inferior vena cava filters. Arch Intern Med 2004;164: 1541-1545.
33. Stamm JA. Risk stratification for acute pulmonary embolism. Crit Care Clin 2012;28: 301-321.
34. White RH, Zhou H, Kim J, et al. A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism. Arch Intern Med 2000;160: 2033-2041.